Derivation of cutoffs for the Elecsys® amyloid β (1–42) assay in Alzheimer's disease

Derivation of cutoffs for the Elecsys® amyloid β (1–42) assay in Alzheimer's disease

Abstract Introduction An Elecsys® Amyloid β (Aβ [1–42]) immunoassay cutoff for classification of patients with Alzheimer's disease was investigated. Methods Cerebrospinal fluid samples collected from patients with mild‐to‐moderate Alzheimer's disease were analyzed by Elecsys® immunoassays:...

Full description

Bibliographic Details
Main Authors: Leslie M. Shaw, Teresa Waligorska, Leona Fields, Magdalena Korecka, Michal Figurski, John Q. Trojanowski, Udo Eichenlaub, Simone Wahl, Marian Quan, Michael J. Pontecorvo, D. Richard Lachno, Jayne A. Talbot, Scott W. Andersen, Eric R. Siemers, Robert A. Dean
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
Subjects:
Alzheimer's disease
Biomarkers
Immunoassay
Amyloid β
Cerebrospinal fluid
Method comparison
Online Access:https://doi.org/10.1016/j.dadm.2018.07.002

Internet

https://doi.org/10.1016/j.dadm.2018.07.002

Similar Items